Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 20 studies | 69% ± 26% | |
oligodendrocyte precursor cell | 15 studies | 61% ± 19% | |
glutamatergic neuron | 9 studies | 39% ± 21% | |
GABAergic neuron | 8 studies | 45% ± 15% | |
retinal rod cell | 7 studies | 38% ± 19% | |
retinal cone cell | 7 studies | 30% ± 11% | |
endothelial cell | 6 studies | 31% ± 14% | |
retinal bipolar neuron | 5 studies | 27% ± 11% | |
interneuron | 5 studies | 39% ± 18% | |
neuron | 4 studies | 32% ± 9% | |
GABAergic interneuron | 3 studies | 28% ± 9% | |
granule cell | 3 studies | 34% ± 20% | |
OFF-bipolar cell | 3 studies | 63% ± 5% | |
rod bipolar cell | 3 studies | 30% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 98% | 108593.88 | 2599 / 2642 | 99% | 141.36 | 701 / 705 |
liver | 37% | 1848.34 | 83 / 226 | 62% | 7.80 | 250 / 406 |
breast | 0% | 0 | 0 / 459 | 58% | 3.45 | 654 / 1118 |
pancreas | 42% | 1754.11 | 137 / 328 | 13% | 0.30 | 24 / 178 |
adrenal gland | 5% | 502.07 | 14 / 258 | 44% | 1.80 | 101 / 230 |
prostate | 0% | 0 | 0 / 245 | 7% | 0.13 | 35 / 502 |
lymph node | 0% | 0 | 0 / 0 | 7% | 0.17 | 2 / 29 |
uterus | 0% | 0 | 0 / 170 | 6% | 0.14 | 29 / 459 |
lung | 0% | 0 | 0 / 578 | 6% | 0.15 | 69 / 1155 |
ovary | 0% | 0 | 0 / 180 | 5% | 0.12 | 22 / 430 |
stomach | 1% | 31.34 | 3 / 359 | 4% | 0.12 | 11 / 286 |
tonsil | 0% | 0 | 0 / 0 | 4% | 0.08 | 2 / 45 |
esophagus | 0% | 4.47 | 2 / 1445 | 4% | 0.08 | 7 / 183 |
intestine | 0% | 10.85 | 1 / 966 | 3% | 0.09 | 18 / 527 |
kidney | 0% | 0 | 0 / 89 | 3% | 0.11 | 31 / 901 |
eye | 0% | 0 | 0 / 0 | 3% | 0.13 | 2 / 80 |
thymus | 0% | 0 | 0 / 653 | 2% | 0.04 | 12 / 605 |
skin | 0% | 3.45 | 2 / 1809 | 2% | 0.06 | 8 / 472 |
bladder | 0% | 0 | 0 / 21 | 2% | 0.10 | 9 / 504 |
muscle | 0% | 3.87 | 1 / 803 | 0% | 0 | 0 / 0 |
heart | 0% | 8.64 | 1 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
adipose | 0% | 0 | 0 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 0% | 0 | 0 / 1335 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0070779 | Biological process | D-aspartate import across plasma membrane |
GO_0070778 | Biological process | L-aspartate transmembrane transport |
GO_0043200 | Biological process | response to amino acid |
GO_0046326 | Biological process | positive regulation of glucose import |
GO_1903712 | Biological process | cysteine transmembrane transport |
GO_0098656 | Biological process | monoatomic anion transmembrane transport |
GO_0150104 | Biological process | transport across blood-brain barrier |
GO_0070633 | Biological process | transepithelial transport |
GO_0015813 | Biological process | L-glutamate transmembrane transport |
GO_0006811 | Biological process | monoatomic ion transport |
GO_0098712 | Biological process | L-glutamate import across plasma membrane |
GO_0035264 | Biological process | multicellular organism growth |
GO_0070207 | Biological process | protein homotrimerization |
GO_0006750 | Biological process | glutathione biosynthetic process |
GO_0098810 | Biological process | neurotransmitter reuptake |
GO_0071314 | Biological process | cellular response to cocaine |
GO_0007268 | Biological process | chemical synaptic transmission |
GO_0006836 | Biological process | neurotransmitter transport |
GO_0030534 | Biological process | adult behavior |
GO_0009410 | Biological process | response to xenobiotic stimulus |
GO_0140009 | Biological process | L-aspartate import across plasma membrane |
GO_0009611 | Biological process | response to wounding |
GO_0007632 | Biological process | visual behavior |
GO_0021537 | Biological process | telencephalon development |
GO_0098796 | Cellular component | membrane protein complex |
GO_0098978 | Cellular component | glutamatergic synapse |
GO_0005886 | Cellular component | plasma membrane |
GO_0045121 | Cellular component | membrane raft |
GO_0016020 | Cellular component | membrane |
GO_0042734 | Cellular component | presynaptic membrane |
GO_0009986 | Cellular component | cell surface |
GO_0030673 | Cellular component | axolemma |
GO_0097449 | Cellular component | astrocyte projection |
GO_0044297 | Cellular component | cell body |
GO_0044306 | Cellular component | neuron projection terminus |
GO_0031982 | Cellular component | vesicle |
GO_0015501 | Molecular function | glutamate:sodium symporter activity |
GO_0008509 | Molecular function | monoatomic anion transmembrane transporter activity |
GO_0015175 | Molecular function | neutral L-amino acid transmembrane transporter activity |
GO_0033229 | Molecular function | cysteine transmembrane transporter activity |
GO_0005313 | Molecular function | L-glutamate transmembrane transporter activity |
GO_0046872 | Molecular function | metal ion binding |
GO_0005314 | Molecular function | high-affinity L-glutamate transmembrane transporter activity |
GO_0005515 | Molecular function | protein binding |
Gene name | SLC1A2 |
Protein name | Amino acid transporter Solute carrier family 1 member 2 Excitatory amino acid transporter 2 (Glutamate/aspartate transporter II) (Sodium-dependent glutamate/aspartate transporter 2) (Solute carrier family 1 member 2) |
Synonyms | EAAT2 hCG_26509 GLT1 |
Description | FUNCTION: Sodium-dependent, high-affinity amino acid transporter that mediates the uptake of L-glutamate and also L-aspartate and D-aspartate . Functions as a symporter that transports one amino acid molecule together with two or three Na(+) ions and one proton, in parallel with the counter-transport of one K(+) ion . Mediates Cl(-) flux that is not coupled to amino acid transport; this avoids the accumulation of negative charges due to aspartate and Na(+) symport . Essential for the rapid removal of released glutamate from the synaptic cleft, and for terminating the postsynaptic action of glutamate (By similarity). . |
Accessions | ENST00000531628.2 ENST00000647372.1 ENST00000647104.1 [P43004-2] ENST00000464522.2 P43004 H0YEB1 A0A2R8Y6J5 ENST00000643401.1 A0A2R8Y642 A0A2R8Y860 A0A2R8Y5Y1 A0A2R8Y4D1 ENST00000646080.1 ENST00000642578.1 ENST00000642171.1 A0A2R8YH93 A0A2R8YD46 A0A163QEF0 ENST00000643134.1 ENST00000646099.1 ENST00000606205.6 ENST00000278379.9 [P43004-1] ENST00000643000.1 [P43004-2] ENST00000449068.2 ENST00000642769.1 C9J9N5 A2A2U1 ENST00000643305.1 [P43004-3] H0YEK4 A0A2R8Y740 A0A2R8YHI4 ENST00000643522.1 A0A2U3U0E3 ENST00000644868.1 ENST00000645303.1 A0A2R8YCL7 A0A2R8Y6B8 A0A2R8YG01 A0A2R8Y4W1 A0A2R8Y4N0 ENST00000646167.1 A0A2U3TZS7 A0A2R8Y862 A0A2R8YFE3 ENST00000644299.1 [P43004-2] ENST00000644351.1 ENST00000395753.6 [P43004-2] ENST00000647076.1 ENST00000644050.1 [P43004-2] ENST00000643454.1 ENST00000644779.1 ENST00000395750.6 ENST00000645194.1 [P43004-2] ENST00000646847.1 ENST00000645634.1 [P43004-2] ENST00000644459.1 |